ArticleFrontiers in cardiovascular medicine2026
Estimated pulse wave velocity and progression to advanced cardiovascular-kidney-metabolic syndrome: a population-based longitudinal study with supportive external cross-sectional evidence.
Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Cardiovascular-kidney-metabolic (CKM) syndrome captures the interconnected burden of metabolic risk factors, chronic kidney disease, and cardiovascular disease. Evidence remains limited regarding simple and clinically accessible markers that may help identify individuals at risk of progression to advanced CKM syndrome. We evaluated whether estimated pulse wave velocity (ePWV), an easily calculated marker of arterial stiffness, was associated with progression to advanced CKM syndrome. Methods: We analyzed longitudinal data from the China Health and Retirement Longitudinal Study, with baseline assessment in 2011 and follow-up assessments in 2013 and 2015. Multivariable logistic regression examined associations of baseline ePWV, longitudinal changes in ePWV, and ePWV trajectories with progression to advanced CKM syndrome. Subgroup, inverse probability weighting, restricted cubic spline, and receiver operating characteristic analyses were performed. We also assessed cross-sectional associations in an independent hospital-based cohort. Results: The longitudinal analysis included 5,810 participants. In fully adjusted models, higher baseline ePWV was associated with greater odds of progression to advanced CKM syndrome. Compared with participants in the lowest ePWV tertile, those in the highest tertile had significantly higher odds of CKM progression [odds ratio [OR] = 2.630; 95% confidence interval [CI]: 2.004-3.451; Conclusions: Higher baseline ePWV, greater longitudinal increases in ePWV, and a persistently higher ePWV trajectory were associated with progression to advanced CKM syndrome. ePWV may serve as a convenient adjunctive marker for early CKM risk stratification, while its interpretation should consider its dependence on age and blood pressure.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.